Endpoint definition
↥| Name | FIBROSCLEROLIV |
|---|---|
| Long name | Fibrosis and sclerosis of liver |
| Hospital Discharge registry | ICD-10: K742 |
| Cause of Death registry | ICD-10: K742 |
| First defined in version | DF2 |
| Latin name | Fibrosis et sclerosis hepatis |
Fibrosis and sclerosis of liver
cirrhosis of liver: A disorder characterized by replacement of the liver parenchyma with fibrous tissue and regenerative nodules. It is usually caused by alcoholism, hepatitis B, and hepatitis C. Complications include the development of ascites, esophageal varices, bleeding, and hepatic encephalopathy.
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 16 | 13 | - |
| Unadjusted prevalence (%) | 0.01 | 0.01 | - |
| Mean age at first event (years) | 54.62 | 53.53 | - |
| Case fatality at 5-years (%) | 6.25 | 7.69 | - |
Longitudinal metrics
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 1.0 | 1.0 | - |
| Recurrence at 6 months (%) | 43.75 | 38.46 | - |
Survival analyses between endpoints
↥Plot
before Fibrosis and sclerosis of liver
after Fibrosis and sclerosis of liver
Loading survival analyses plot…
Table
Loading survival analyses table…